Sanofi Quarterly Results 2024. Revenue in q1 came in at $11.36 billion, 2.6% more than analysts had predicted. These results confirm the positive phase 2 data with additional details to be presented at forthcoming medical meetings and a regulatory submission later this year.
Third quarter 2024 results will be reviewed by management during a live audio webcast with the financial community on october 25 th, 2024. First quarter 2024 results were reviewed by management during a conference call with the financial community on april 25 th.
Reported Eps Is $0.96 Eps, Expectations Were $0.96.
Sanofi last posted its quarterly earnings results on february 1st, 2024.
Fourth Quarter And Full Year 2023 Results Were Reviewed By Management During A Live Audio Webcast With The Financial Community On.
First quarter 2023 results were reviewed by management during a live audio webcast with the financial community.
These Results Confirm The Positive Phase 2 Data With Additional Details To Be Presented At Forthcoming Medical Meetings And A Regulatory Submission Later This Year.
Images References :
Thank You For Joining Us To Review Sanofi's Fourth Quarter And Full Year 2023 Results, Followed By A Q&Amp;A Session.
Revenue in q1 came in at $11.36 billion, 2.6% more than analysts had predicted.
Second Quarter 2023 Results Were Reviewed By Management During A Live Audio Webcast With The Financial Community.
Fourth quarter and full year 2023 results were reviewed by management during a live audio webcast with the financial community on.
As Usual, You Can Find The Slides To This Call On The.